The impact of the COVID-19 pandemic on SLE

Xingwang Zhao1, Haohao Wu1, Shifei Li1

  • 1Department of Dermatology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.

Modern Rheumatology
|March 24, 2023
PubMed

Insights

Systemic lupus erythematosus (SLE) patients faced many COVID-19 concerns. This review highlights shared inflammatory pathways, risks, and treatment options for SLE patients during the pandemic.

Area of Science:

  • Immunology
  • Rheumatology
  • Infectious Diseases

Background:

  • The association between coronavirus disease 2019 (COVID-19) and autoimmune diseases, particularly systemic lupus erythematosus (SLE), remains incompletely understood.
  • SLE patients encountered numerous challenges during the COVID-19 pandemic, including infection risk, disease management, and vaccination decisions.
  • Shared inflammatory pathways and immuno-inflammatory responses exist between SLE and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Approach:

  • A comprehensive literature review was conducted to explore the multifaceted effects of the COVID-19 pandemic on patients with SLE.
  • The review discusses clinical characteristics, pathological features, and cytokine profiles relevant to both SLE and SARS-CoV-2 infection.
  • Epidemiological data, therapeutic strategies, and vaccination efficacy for SLE patients during the pandemic are analyzed.

Key Points:

  • Current data are insufficient to fully assess COVID-19 risk and severity in SLE patients.
  • Hydroxychloroquine and chloroquine are ineffective for COVID-19 prevention.
  • SLE patients experienced higher hospitalization rates during the pandemic; vaccination is recommended to mitigate infection risk.

Conclusions:

  • SARS-CoV-2 infection shares clinical and immunological similarities with SLE, necessitating careful management.
  • Vaccination is crucial for reducing infection risk in SLE patients.
  • This review provides valuable insights into the diagnosis, treatment, and prevention of COVID-19 in SLE patients.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
11
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
571
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
12
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
21
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
295
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.3K